Inhaled Low‐Dose Iloprost for Pulmonary Hypertension: A Prospective, Multicenter, Open‐Label Study

BACKGROUND: Inhaled iloprost (average >30 µg/d) has been considered an effective treatment for severe pulmonary hypertension (PH). Further evidence also showed that low‐dose iloprost given intravenously was equally effective as high‐dose iloprost in the therapy of systemic sclerosis. HYPOTHESIS:...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Cardiol
Autors principals: Sun, Yun‐Juan, Xiong, Chang‐Ming, Shan, Guang‐Liang, Gu, Qing, Zeng, Wei‐Jie, Lu, Xian‐Ling, Zhu, Feng, Liu, Zhi‐Hong, Ni, Xin‐Hai, He, Jian‐Guo
Format: Artigo
Idioma:Inglês
Publicat: Wiley Periodicals, Inc. 2012
Matèries:
Clinical Investigations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6652663/
https://ncbi.nlm.nih.gov/pubmed/22488211
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.21987
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars